LabCorp's Esoterix and DHMRI Collaborate on Assay Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America division Esoterix Clinical Trial Services today announced a deal with the David H. Murdock Research Institute for assay development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.